mechanism of action of glp-1 receptor agonists Glucagon-like peptide 1 agonists: cardiovascular benefits and mechanisms Mechanism of action of GLP-1

Among those on the highest dose, 54.6% achieved at least 10% weight loss, 36.0% achieved 15% or more, and 18.4% achieved 20% or more

The online/direct-to-consumer (DTC) segment is expected to grow at the fastest CAGR in the coming years due to the increasing preference for home delivery and digital access to medications, which offers convenience and privacy for patients managing chronic obesity

The growing patient population creates sustained demand for effective therapies for glycemic control

The exception is that Zepbound is FDA-approved to treat excess weight and obesity and Mounjaro is FDA-approved to treat type 2 diabetes

GLP-1s include Novo Nordisk's blockbuster weight loss injection Wegovy and diabetes counterpart Ozempic, along with Eli Lilly's popular weight loss treatment Zepbound and diabetes injection Mounjaro